BlackRock Inc. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 191 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28,193,917
-32.8%
8,893,980
+5.3%
0.00%0.0%
Q2 2023$41,976,869
-6.9%
8,446,050
-7.4%
0.00%0.0%
Q1 2023$45,068,073
-19.4%
9,123,092
+2.7%
0.00%
-50.0%
Q4 2022$55,896,538
-37.0%
8,886,572
+8.2%
0.00%
-33.3%
Q3 2022$88,696,000
-2.8%
8,212,580
+2.6%
0.00%0.0%
Q2 2022$91,260,000
+41.4%
8,005,166
+13.0%
0.00%
+50.0%
Q1 2022$64,557,000
-33.7%
7,086,233
+8.6%
0.00%0.0%
Q4 2021$97,368,000
-47.9%
6,525,954
-10.2%
0.00%
-60.0%
Q3 2021$186,868,000
+2.0%
7,271,192
+3.5%
0.01%0.0%
Q2 2021$183,132,000
-17.3%
7,021,939
+12.0%
0.01%
-28.6%
Q1 2021$221,334,000
+35.5%
6,270,078
-3.1%
0.01%
+40.0%
Q4 2020$163,372,000
-31.4%
6,472,760
+2.5%
0.01%
-44.4%
Q3 2020$238,051,000
-4.0%
6,312,703
+9.0%
0.01%
-10.0%
Q2 2020$248,017,000
+160.2%
5,792,119
+18.1%
0.01%
+100.0%
Q1 2020$95,305,000
-27.0%
4,902,584
-2.4%
0.01%0.0%
Q4 2019$130,544,000
+19.6%
5,024,772
+25.5%
0.01%0.0%
Q3 2019$109,130,000
+14.1%
4,004,019
+12.4%
0.01%
+25.0%
Q2 2019$95,650,000
+47.0%
3,562,333
+58.3%
0.00%
+33.3%
Q1 2019$65,056,000
+16.1%
2,250,277
+8.2%
0.00%0.0%
Q4 2018$56,011,0002,079,8290.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders